The interferon stimulated gene 15 functions as a proviral factor for HCV and is enhanced in the liver of patients with genotype 1

Zeitschrift für Gastroenterologie ◽

10.1055/s-0029-1191926 ◽

2009 ◽

Vol 47 (01) ◽

Author(s):

R Bröring ◽

M Trippler ◽

G Gerken ◽

JF Schlaak

Keyword(s):

Interferon Stimulated Gene 15

Download Full-text

Predictors of relapse in genotype 1 patients treated with PegIFN-alfa2b and ribavirin due to chronic hepatitis C within a large German multicentric observational study

Zeitschrift für Gastroenterologie ◽

10.1055/s-0028-1089437 ◽

2008 ◽

Vol 46 (09) ◽

Author(s):

S Mauss ◽

D Hueppe ◽

M Manns ◽

G Teuber ◽

T Dahhan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Chronic Hepatitis C ◽

Download Full-text

Treatment of Genotype 1 HCV Treatment-Naïve Patients: final results of phase III study ADVANCE

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1269659 ◽

2011 ◽

Vol 49 (01) ◽

Author(s):

T Berg ◽

P Buggisch ◽

P Malinski ◽

H Diepolder ◽

S Mauss ◽

...

Keyword(s):

Phase Iii ◽

Hcv Treatment ◽

Treatment Naïve ◽

Phase Iii Study

Download Full-text

IL28B genetic variation and ratio of y-GT/ALT as predictors for virological response in chronic hepatitis C virus genotype 1 infected patients

Zeitschrift für Gastroenterologie ◽

10.1055/s-0031-1295892 ◽

2012 ◽

Vol 50 (01) ◽

Author(s):

A Amanzada ◽

S Schneider ◽

F Moriconi ◽

M Blaschke ◽

T Suermann ◽

...

Keyword(s):

Genetic Variation ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virological Response ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Download Full-text

Thyroid dysfunction induced by peginterferon alfa-2b (Peg-2b)/Ribavirin (RBV) is a favorable predictor of SVR in difficult-to-treat patients with HCV Genotype 1 (G1) infection

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1324001 ◽

2012 ◽

Vol 50 (08) ◽

Author(s):

S Mauss ◽

D Hueppe ◽

E Zehnter ◽

MP Manns ◽

G Teuber ◽

...

Keyword(s):

Thyroid Dysfunction ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Peginterferon Alfa

Download Full-text

Treatment of chronic hepatitis C Genotype 1 (G1) infection with boceprevir (Victrelis®) in the German real-life setting: First results for treatment-naïve patients from the Novus observational study

Zeitschrift für Gastroenterologie ◽

10.1055/s-0033-1352957 ◽

2013 ◽

Vol 51 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Chronic Hepatitis C ◽

Real Life ◽

Real Life Setting ◽

First Results ◽

Treatment Naïve

Download Full-text

Real world experience in 150 genotype 1 HCV patients with triple therapy: severe adverse events and high rates of virological failure in cirrhotic patients with portal hypertension (platelets < 100.000/nl and albumine < 40 g/l)

Zeitschrift für Gastroenterologie ◽

10.1055/s-0033-1352750 ◽

2013 ◽

Vol 51 (08) ◽

Author(s):

J Petersen ◽

K Voelker ◽

K Olah ◽

K Matschenz ◽

H Wolski ◽

...

Keyword(s):

Portal Hypertension ◽

Adverse Events ◽

Triple Therapy ◽

Virological Failure ◽

Cirrhotic Patients ◽

Severe Adverse Events

Download Full-text

High virologic response rate at End of Treatment (EOT) following triple therapy of previously untreated HCV Genotype 1 (G1) infection with boceprevir in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1386302 ◽

2014 ◽

Vol 52 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rate ◽

Real Life ◽

Virologic Response ◽

Hcv Genotype ◽

End Of Treatment ◽

Hcv Genotype 1 ◽

Virologic Response Rate

Download Full-text

Baseline predictors of an early virologic response (EVR) in previously untreated patients undergoing boceprevir (BOC) triple therapy for HCV genotype 1 infection in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1397212 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Early Virologic Response ◽

Hcv Genotype ◽

Download Full-text

Baseline gamma-GT levels within the normal range predict high virologic response rates in treatment-naïve patients undergoing boceprevir triple therapy for HCV genotype 1 (G1) infection

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1397211 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

HF Löhr ◽

G Teuber ◽

H Steffens ◽

MR Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rates ◽

Virologic Response ◽

Normal Range ◽

Hcv Genotype ◽

Treatment Naïve ◽

Download Full-text

Efficacy and safety of Boceprevir triple therapy in previously treated patients with HCV Genotype 1 (G1) infection in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1567991 ◽

2015 ◽

Vol 53 (12) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Efficacy And Safety ◽

Hcv Genotype ◽

Previously Treated Patients ◽

Previously Treated ◽

Download Full-text